A modified protein in benign-appearing meningiomas can reveal which are truly benign and which are more dangerous and require more aggressive treatment, researchers have discovered.
Nov 5, 2019
0
30
Meningiomas, a type of brain tumour, are usually easy to treat. However, there are a few subtypes that follow a very aggressive course and have high recurrence rates, i.e. there is a high risk of them coming back after treatment. ...
Nov 19, 2018
0
3
The vast majority of meningiomas—tumors that form from the membranes surrounding the brain and spinal cord—are slow-growing and benign. "Atypical" meningiomas have a more aggressive clinical course, and patients with ...
Jan 30, 2018
0
2
Meningiomas—tumors that arise from the lining of the brain and spinal cord—have recently been in the news with celebrities Kate Walsh and Maria Menounos sharing their initial shock upon diagnosis and their experiences ...
Sep 29, 2017
0
300
Being overweight or obese may be tied to an increased risk of a type of brain tumor called meningioma, according to a new meta-analysis published in the September 16, 2015, online issue of Neurology, the medical journal of ...
Sep 16, 2015
0
21
In people under age 30, radiation is a risk factor for a type of brain tumor called a meningioma, a Loyola University Medical Center study has found.
Nov 3, 2014
0
0
Johns Hopkins researchers say they have found a specific protein in nearly 100 percent of high-grade meningiomas—the most common form of brain tumor—suggesting a new target for therapies for a cancer that does not respond ...
Aug 27, 2013
0
0
Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15 percent of brain tumors known as meningiomas, a finding that could lead to the first effective drug treatments for the tumors, report ...
Jan 22, 2013
0
1
A diagnosis of a brain tumor can be frightening. Of the more than 100 types of brain tumors, meningioma and glioblastoma are two of the most common.
Aug 14, 2023
0
1
A new research paper titled "Association between tumor mutations and meningioma recurrence in Grade I/II disease" has been published in Oncoscience.
Jan 17, 2023
0
1
